ACD/Labs and MilliporeSigma Expand Partnership to Advance Digital, Sustainable Compound Verification & Quantification by NMR and IR
ACD/Labs is pleased to expand its partnership with MilliporeSigma (the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany), building on the 2023 collaboration that launched the first digital reference material (dRM) platform, ChemisTwin™ Platform. As part of this next phase, ACD/Labs will provide commercial sales support to bring this transformative solution to more laboratories worldwide.
ChemisTwin™ Platform integrates ACD/Labs’ industry-leading NMR prediction and analytical data management capabilities with MilliporeSigma’s digital reference materials to deliver a standardized, fast, reliable, and reagent-free approach to compound identity verification. Designed for QA/QC labs in the pharmaceutical, biopharmaceutical, chemical, food & beverage sectors—as well as academic institutions—ChemisTwin™ Platform helps reduce reliance on physical reference standards, supporting sustainability initiatives while streamlining workflows, improving efficiency, and enhancing regulatory compliance.
This cloud-based platform empowers laboratories to embrace digital transformation and operate more efficiently and responsibly.